Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Verhoogd risico op cardiovasculaire events en VTE na diagnose hersentumor
jan 2024 | Neuro-oncologie